Arm's stock has surged 160% this year, driven by strong demand for its first in-house AGI CPU, which has over $2 billion in orders. Despite revenue growth and expanding data center business, the stock trades at a high forward P/E of 118, causing analysts to rate it a hold with a price target slightly below current levels. Key risks include an upcoming trial with Qualcomm and export controls affecting China revenue. Future stock performance depends on AGI CPU adoption and legal outcomes.
Arm's ambitious push into AGI CPUs comes as its stock trades at USD 288.56 on Pluang, down 1.74% as of Oct 01, 2026 01:11 WIB. Despite the recent dip, Arm's market cap remains substantial at $313.64 billion. Meanwhile, Qualcomm shares are relatively stable at USD 184.12, down just 0.05%, with a market cap of $196.63 billion, reflecting ongoing investor interest amid the legal and export challenges noted in the news.
Shares of Arm Holdings (ARM) broke out of a double bottom pattern last week, indicating a bullish reversal after a recent bearish correction. The breakout above $299.29 was supported by strong volume and reclaiming key moving averages, suggesting imp...
Chip stocks are recovering after a sharp selloff, with Arm Holdings leading the rebound by rising 5%. This recovery highlights renewed investor interest in semiconductors, especially those tied to artificial intelligence and data center growth. Marve...
Arm Holdings' stock dropped 9%, significantly more than peers Qualcomm and Marvell, amid a broader semiconductor selloff driven by inflation concerns and rising oil prices. The selloff is intensified by profit taking after Arm's 158% year-to-date gai...
